I have now spent fifteen minutes haranguing on about a per se illegality rule as applied to reverse payment settlement agreements. Seriously. Reverse payment settlement agreements. Sounds unbearably dull, admittedly. But actually, in what I assume is some form of Stockholm Syndrom, I’m finding it pretty interesting. Idea is this: brand-name drug company puts out Drug A. [...]